Erlotinib (Tarceva®) induced severe exanthema

被引：0
|
作者：
Fernandez-Guarino, M. [1 ]
Lopez, P. Garrido
Gonzalez-Garcia, C.
Jaen, P.
机构：
[1] Hosp Ramon & Cajal, Serv Dermatol, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Serv Oncol, E-28034 Madrid, Spain
[3] Hosp Ramon & Cajal, Serv Anat Patol, E-28034 Madrid, Spain
来源：
REVISTA CLINICA ESPANOLA | 2007年 / 207卷 / 08期
关键词：
D O I：
10.1157/13108767
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：422 / 423
页数：2
相关论文
共 50 条
  • [21] Erlotinib/pembrolizumabLichenoid exanthema, subacute cutaneous lupus erythematosus and papulopustular exanthema: 3 case reports
    Reactions Weekly, 2022, 1931 (1) : 259 - 259
  • [22] Targeting the epidermal growth factor receptor by erlotinib (Tarceva™) for the treatment of esophageal cancer
    Sutter, AP
    Höpfner, M
    Huether, A
    Maaser, K
    Scherübl, H
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (07) : 1814 - 1822
  • [23] Survival benefit from erlotinib (TARCEVA®) in NSCLC patients with good prognostic factors
    Cagnoni, Pablo
    Christy-Bittel, Janna
    McCarthy, Sean
    Clark, Gary
    ANNALS OF ONCOLOGY, 2006, 17 : 235 - 235
  • [24] Modulation of the radiosensitivity of U343 glioblastoma cells through erlotinib (Tarceva)
    Milanovic, D.
    Lohr, F.
    Wertz, F.
    Herskind, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 84 - 84
  • [25] Phase II trial of erlotinib (Tarceva) in women with squamous cell carcinoma of the vulva
    Horowitz, N.
    Olawaiye, A.
    Growdon, W.
    Borger, D.
    Dizon, D.
    Brard, L.
    Matulonis, U.
    MacNeill, K.
    Roche, M.
    Krasner, C.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S14 - S14
  • [26] Tarceva - Erlotinib - Genentech/Osi pharmaceuticals - Tyrosine kinase inhibitor approved for NSCLC
    不详
    FORMULARY, 2004, 39 (12) : 568 - 568
  • [27] DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL
    Desjardins, Annick
    Peters, Katherine B.
    Vredenburgh, James J.
    Friedman, Henry S.
    Reardon, David A.
    NEURO-ONCOLOGY, 2010, 12 : 51 - 51
  • [28] Severe Maculopapular Exanthema Induced by Regorafenib: Successful Desensitization and Adaptation of a Dosage Regimen
    Garcia-Gutierrez, I
    Acevedo, M.
    Tornero, P.
    Matilla, A.
    Marquez, L.
    Sanchez-Herrero, A.
    Prieto-Garcia, A.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (04) : 300 - +
  • [29] Dabigatran induced exanthema
    Cucurull i Canosa, J.
    Vega-Molpeceres, S.
    Just Sarobe, M.
    Escoda Garcia, M.
    REVISTA CLINICA ESPANOLA, 2010, 210 (11): : 590 - 591
  • [30] Erlotinib (Tarceva®) in patients with non-small-cell lung cancer (NSCLC): results on 394 patients from Tarceva Register of Czech Republic
    Skrickova, Jana
    Pesek, Milos
    Zatloukal, Petr
    Kolek, Vitezslav
    Koubkova, Leona
    Salajka, Frantisek
    Zemanova, Milada
    Tomiskova, Marcela
    Sixtova, Dimka
    Pavlik, Tomas
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S714 - S714
12345